Reality star Gemma Collins has shared some information about her recent weight loss, the star has lost two stone following Mounjaro injections which she started earlier in the year. The former TOWIE star debuted her transformation whilst attending the Chelsea Flower Show, where she said the injections have decreased her appetite a significant amount. Collins says she is now a UK size 20 and down from size 26.
Collins said she started the injections via the NHS back in January, and that she started seeing her body changing within weeks. She described the injections as "life-changing" and that it helped her feel full, which was easier to manage and gauge what she was eating.
However, Collins went on to describe some of the downfalls of the injections. Collins discussed, she was "worried" about the impact the weight loss has had on her face, she hated how her wrinkles were deeper and fuller less, which could be described as "Ozempic face". Collins said she was pleased with the weight loss but felt that she had to be mindful of the side effects.
She mentioned that anyone thinking about doing any similar treatments should consult a medical professional, but they shouldn't go into the treatments thinking that they are a quick fix. Collins thoughts reflect the potential outcomes and aspects of taking prescription weight loss drugs.
This week’s NHS press release about weight loss injections made headlines.
— Ankit Kant (@ankitkant) June 24, 2025
But here’s what didn’t:
Most GPs can’t offer it.
It hasn’t been funded safely or commissioned in most areas.
We’re left to pick up the pieces. pic.twitter.com/ubks16JfX6
Advertising Watchdog Bans Gemma Collins’ Instagram Post
Gemma Collins has received heavy criticism after one of her social media posts promoting a weight-loss service was found to violate advertising rules. The UK’s Advertising Standards Authority (ASA) banned her Instagram post because it promoted a prescription-only treatment, which is not permitted under the current advertising laws.
The advertising post referenced Yazen, a company that delivers weight-loss injections including Mounjaro. The ASA indicated that such promotion could only be done by licensed medical professionals and not celebrities or influencers. Collins later admitted the mistake and said she would ensure any future posts comply with all guidelines.
The episode raised questions about how weight-loss treatments are being advertised and publicized online. In recent comments, Collins noted that she urged members of the public to be mindful when using these medications and to use them only with appropriate medical supervision.
She highlighted and warned that there is an emerging trend of people casually using these medications or obtaining them without a real medical need.
Collins emphasized that these treatments should be prescribed for people who actually need them (e.g., people with obesity, diabetes, etc.), not for people seeking rapid cosmetic changes.
Her experience has increased the emphasis on the dangers of self-medicating, as well as the importance of responsible messaging about medications on social media .
